Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shapiro

Showing results (1071-1080 of 1,392) with videos related to

Pageof 140
Sort By:
Blood|May 22, 2025
Plasminogen activation and plasmin activity are not required to prevent venous thrombosis/thromboembolismYaqiu Sang, Marzia Menegatti, Jennifer A Brody, et al.
Journal of the American Heart Association|March 17, 2023
Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular EventsIsaac Acquah, Kobina Hagan, Zulqarnain Javed, et al.
Functional Ecology|September 20, 2023
Toxin tolerance across landscapes: Ecological exposure not a prerequisiteM Denise Dearing, Teri J Orr, Dylan M Klure, et al.
Atherosclerosis|June 27, 2022
Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary preventionAbdulhamied Alfaddagh, Karan Kapoor, Zeina A Dardari, et al.
Blood|August 25, 2019
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial resultsAmy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, et al.
Academic Pediatrics|November 15, 2021
Development and Validation of a Natural Language Processing Tool to Identify Injuries in Infants Associated With AbuseGunjan Tiyyagura, Andrea G Asnes, John M Leventhal, et al.
Journal of the American College of Cardiology|October 1, 2021
Hepatic Sensing Loop Regulates PCSK9 Secretion in Response to Inhibitory AntibodiesCarlota Oleaga, Michael D Shapiro, Joshua Hay, et al.
Diabetes, Obesity & Metabolism|June 4, 2010
A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetesM S Kipnes, P Hollander, K Fujioka, et al.
Neurosurgical Focus|July 28, 2022
Cerebral vasospasm following arteriovenous malformation rupture: a population-based cross-sectional studyAlis J Dicpinigaitis, Eric Feldstein, Steven D Shapiro, et al.
Clinical Endocrinology|October 30, 2009
Exaggerated adrenarche in a cohort of Scottish children: clinical features and biochemistryW F Paterson, S F Ahmed, L Bath, et al.
Pageof 140

Showing results (1071-1080 of 1,392) with videos related to

Sort By:
Pageof 140
Blood|May 22, 2025
Plasminogen activation and plasmin activity are not required to prevent venous thrombosis/thromboembolismYaqiu Sang, Marzia Menegatti, Jennifer A Brody, et al.
Journal of the American Heart Association|March 17, 2023
Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular EventsIsaac Acquah, Kobina Hagan, Zulqarnain Javed, et al.
Functional Ecology|September 20, 2023
Toxin tolerance across landscapes: Ecological exposure not a prerequisiteM Denise Dearing, Teri J Orr, Dylan M Klure, et al.
Atherosclerosis|June 27, 2022
Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary preventionAbdulhamied Alfaddagh, Karan Kapoor, Zeina A Dardari, et al.
Blood|August 25, 2019
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial resultsAmy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, et al.
Academic Pediatrics|November 15, 2021
Development and Validation of a Natural Language Processing Tool to Identify Injuries in Infants Associated With AbuseGunjan Tiyyagura, Andrea G Asnes, John M Leventhal, et al.
Journal of the American College of Cardiology|October 1, 2021
Hepatic Sensing Loop Regulates PCSK9 Secretion in Response to Inhibitory AntibodiesCarlota Oleaga, Michael D Shapiro, Joshua Hay, et al.
Diabetes, Obesity & Metabolism|June 4, 2010
A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetesM S Kipnes, P Hollander, K Fujioka, et al.
Neurosurgical Focus|July 28, 2022
Cerebral vasospasm following arteriovenous malformation rupture: a population-based cross-sectional studyAlis J Dicpinigaitis, Eric Feldstein, Steven D Shapiro, et al.
Clinical Endocrinology|October 30, 2009
Exaggerated adrenarche in a cohort of Scottish children: clinical features and biochemistryW F Paterson, S F Ahmed, L Bath, et al.
Pageof 140